Compare CCCC & VMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CCCC | VMD |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 404.7M | 369.2M |
| IPO Year | 2020 | 2018 |
| Metric | CCCC | VMD |
|---|---|---|
| Price | $4.17 | $9.84 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $12.20 | N/A |
| AVG Volume (30 Days) | ★ 2.9M | 237.7K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 16.45 | ★ 32.14 |
| EPS | N/A | ★ 0.06 |
| Revenue | $35,947,000.00 | ★ $270,280,000.00 |
| Revenue This Year | N/A | $17.88 |
| Revenue Next Year | N/A | $14.98 |
| P/E Ratio | ★ N/A | $159.33 |
| Revenue Growth | 1.02 | ★ 20.52 |
| 52 Week Low | $1.36 | $5.93 |
| 52 Week High | $4.60 | $10.18 |
| Indicator | CCCC | VMD |
|---|---|---|
| Relative Strength Index (RSI) | 62.85 | 55.50 |
| Support Level | $2.13 | $9.22 |
| Resistance Level | N/A | $10.05 |
| Average True Range (ATR) | 0.37 | 0.33 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 70.09 | 84.17 |
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.